Alzheimer's disease Trials in Szczecin, Poland
Conditions / Alzheimer's disease / Szczecin, Poland
Research into Alzheimer's disease spans multiple therapeutic approaches and trial phases.
21 total trials for this combination
Showing top 10 of 21 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02484547 | 221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease | TERMINATED | PHASE3 |
| NCT02079246 | Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's Disease | COMPLETED | PHASE3 |
| NCT01900665 | Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo | TERMINATED | PHASE3 |
| NCT02783573 | A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia | TERMINATED | PHASE3 |
| NCT03114657 | A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD) | TERMINATED | PHASE3 |
| NCT04241068 | A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205 | TERMINATED | PHASE3 |
| NCT03289143 | A Study to Evaluate the Efficacy and Safety of Semorinemab in Patients With Prodromal to Mild Alzheimer's Disease | TERMINATED | PHASE2 |
| NCT01955161 | Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil | COMPLETED | PHASE3 |
| NCT02585934 | Study Evaluating Intepirdine (RVT-101) in Subjects With Mild to Moderate Alzheimer's Disease on Donepezil: MINDSET Study | COMPLETED | PHASE3 |
| NCT02586909 | 12-Month Open-Label Extension Study of Intepirdine (RVT-101) in Subjects With Alzheimer's Disease: MINDSET Extension | TERMINATED | PHASE3 |